Compare BNTX & DRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTX | DRI |
|---|---|---|
| Founded | 2008 | 1968 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 20.2B |
| IPO Year | 2019 | 1995 |
| Metric | BNTX | DRI |
|---|---|---|
| Price | $98.56 | $202.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 25 |
| Target Price | $137.40 | ★ $221.76 |
| AVG Volume (30 Days) | 1.1M | ★ 1.9M |
| Earning Date | 11-03-2025 | 12-18-2025 |
| Dividend Yield | N/A | ★ 2.96% |
| EPS Growth | N/A | ★ 9.17 |
| EPS | N/A | ★ 9.54 |
| Revenue | $3,698,814,972.00 | ★ $12,576,500,000.00 |
| Revenue This Year | $2.03 | $9.83 |
| Revenue Next Year | N/A | $4.00 |
| P/E Ratio | ★ N/A | $21.22 |
| Revenue Growth | 3.70 | ★ 8.61 |
| 52 Week Low | $81.20 | $169.00 |
| 52 Week High | $126.77 | $228.27 |
| Indicator | BNTX | DRI |
|---|---|---|
| Relative Strength Index (RSI) | 56.16 | 70.78 |
| Support Level | $95.85 | $183.34 |
| Resistance Level | $101.48 | $190.68 |
| Average True Range (ATR) | 1.81 | 5.02 |
| MACD | 0.89 | 1.40 |
| Stochastic Oscillator | 70.40 | 90.01 |
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Darden Restaurants is the largest restaurant operator in the US full-service space, with consolidated revenue of $12.1 billion in fiscal 2025. The company maintains a portfolio of 11 restaurant brands: Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Ruth's Chris, Yard House, The Capital Grille, Seasons 52, Eddie V's, Bahama Breeze, The Capital Burger, and most recently, Chuy's. Darden generates revenue almost exclusively from company-owned restaurants, though a small network of franchised restaurants and consumer-packaged goods sales contribute modestly through the traditional grocery channel. As of the end of its fiscal 2025, the company operated 2,159 restaurants in the US.